Legal & General Group’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Buy |
174,910
+39,252
| +29% | +$272K | ﹤0.01% | 2175 |
|
|
2025
Q1 | $1.17M | Sell |
135,658
-3,417
| -2% | -$29.4K | ﹤0.01% | 2131 |
|
|
2024
Q4 | $1.95M | Sell |
139,075
-99,741
| -42% | -$1.4M | ﹤0.01% | 1987 |
|
|
2024
Q3 | $5.4M | Sell |
238,816
-8,998
| -4% | -$204K | ﹤0.01% | 1540 |
|
|
2024
Q2 | $5.02M | Buy |
247,814
+114,746
| +86% | +$2.33M | ﹤0.01% | 1523 |
|
|
2024
Q1 | $3.31M | Buy |
133,068
+263
| +0.2% | +$6.54K | ﹤0.01% | 1714 |
|
|
2023
Q4 | $2.4M | Buy |
132,805
+40,342
| +44% | +$729K | ﹤0.01% | 1861 |
|
|
2023
Q3 | $1.86M | Buy |
92,463
+12,207
| +15% | +$246K | ﹤0.01% | 1931 |
|
|
2023
Q2 | $2.05M | Buy |
80,256
+67,097
| +510% | +$1.71M | ﹤0.01% | 1923 |
|
|
2023
Q1 | $280K | Buy |
13,159
+2,626
| +25% | +$55.9K | ﹤0.01% | 2474 |
|
|
2022
Q4 | $312K | Buy |
10,533
+1,400
| +15% | +$41.4K | ﹤0.01% | 2454 |
|
|
2022
Q3 | $212K | Hold |
9,133
| – | – | ﹤0.01% | 2603 |
|
|
2022
Q2 | $154K | Sell |
9,133
-2,133
| -19% | -$36K | ﹤0.01% | 2727 |
|
|
2022
Q1 | $495K | Buy |
11,266
+1,206
| +12% | +$53K | ﹤0.01% | 2399 |
|
|
2021
Q4 | $612K | Sell |
10,060
-148
| -1% | -$9K | ﹤0.01% | 2355 |
|
|
2021
Q3 | $423K | Buy |
10,208
+2,177
| +27% | +$90.2K | ﹤0.01% | 2469 |
|
|
2021
Q2 | $244K | Buy |
+8,031
| New | +$244K | ﹤0.01% | 2481 |
|